This CME-accredited activity, Dogmas and Controversies in Hematologic Malignancies: West Coast Symposium, features leading experts in hematologic malignancies who will provide a comprehensive overview of current and emerging strategies for the management of Hodgkin and non-Hodgkin lymphoma, chronic lymphocytic leukemia, acute leukemias, myeloproliferative neoplasms and multiple myeloma.

The goal of this activity is to improve the knowledge and competence of learners to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients with hematologic malignancies. The program features in-depth discussion and analysis of recent advances along with scientific debates and panel-based discussions focusing on controversies in the management of hematologic malignancies. Expert faculty will aim to place the role of different therapeutic agents in a clinical context and discuss how to utilize these therapeutic options to effectively contribute to patient care. This conference will highlight a multidisciplinary approach and the integration of new advances in patient-centered care. Physicians, physician assistants, nurse practitioners, pharmacists, nurses, and other healthcare professionals will be updated on the the latest updates in Hematologic Malignancies.